While consolidation—amongst providers, health systems, and payers—is not a new health care industry phenomenon, the latest headlines suggest that the trend is on the rise and is only likely to continue in bigger, bolder ways. Market concentration has implications for the future of delivery system and payment reform as well as for health care costs and patient access and quality. This webinar focused on the implications and tradeoffs of this market shift. Panelists helped define the basics of market concentration and competition, how experts measure the effects on different areas of the market, and how regulators approach assessing partnership proposals. The briefing also highlighted lessons from historical periods of health care consolidation and some key items to watch out for moving forward.
- Matthew Herper, Senior Editor for Pharma and Healthcare, Forbes
- Thomas Scully, General Partner, Welsh, Carson, Anderson & Stowe
- Anu Singh, Managing Director, Kaufman Hall
- Chapin White, Senior Policy Researcher
Moderator: Sarah J. Dash, President and CEO, Alliance for Health Policy